The four reported cancer mutations in Bcl2a1, M75R, L99R, Y120C and, V145L are not located in the proximity of the BH3-binding domain and are not predicted to have any local effects on the complex formation (Fig 5 and S1 Fig). The gene discussed is BCL2A1; the disease is cancer.